RecruitingNCT05399745
BILACO Trial: Biliary Atresia - a Severe Complex Congenital Liver Disease
Studying Isolated biliary atresia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rigshospitalet, Denmark
- Principal Investigator
- Vibeke Brix Christensen, MD, PhD, DMScRigshospitalet, Denmark
- Intervention
- Neurocognitive monitoring(other)
- Enrollment
- 100 target
- Eligibility
- 0-18 years · All sexes
- Timeline
- 2020 – 2040
Study locations (1)
- Rigshospitalet, Copenhagen, Denmark
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05399745 on ClinicalTrials.govOther trials for Isolated biliary atresia
Additional recruiting or active studies for the same condition.
- RECRUITINGEARLY PHASE1NCT07250854The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal CholestasisUniversity of Alabama at Birmingham
- RECRUITINGNANCT06764082Nutritional Intervention for Biliary AtresiaTongji Hospital
- RECRUITINGNANCT06564740Stem Cell Applications in Biliary Atresia PatientsNecmi Kadıoğlu Hospital
- ACTIVE NOT RECRUITINGNCT06184971Biliary Atresia Research Network NortheastYale University
- RECRUITINGNCT05848310Preoperative Serum FGF19 in the Prognosis of Biliary AtresiaChildren's Hospital of Fudan University
- RECRUITINGNANCT05925309Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai PortoenterostomyChildren's Hospital of Fudan University
- ENROLLING BY INVITATIONPHASE3NCT05426733An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary AtresiaAlbireo, an Ipsen Company
- RECRUITINGNCT05072626High Medium-chain Triglyceride Nutritional Support in Infants With Biliary AtresiaChildren's Hospital of Fudan University